Status:
COMPLETED
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
Lead Sponsor:
Mayo Clinic
Conditions:
Brain Imaging
Whole Body Imaging
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the effectiveness of new software available on a new PET/CT scanner in the Molecular Imaging Research PET/CT Facility. Further, the study aims to evaluate the da...
Detailed Description
The study will be separated into three cohorts: Motion Correction, Parametric Imaging, and MAP Reconstruction. The motion correction (Aim 1) cohort will involve a group of 30 subjects who are already ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Subjects who are able and willing to sign the informed consent
- Subjects who are able to follow verbal commands
- A negative urine pregnancy test within 48 hours prior to PET imaging procedures in females of childbearing potential
- Subjects who are scheduled for a PET/CT study under Mayo Clinic Rochester IRB research protocol 08-005553 (Aim 1 cohort only)
- A positive 18F-FDG oncology PET/CT exam in the last six months (Aim 2 cohort only)
Exclusion
- Patients who are unable to lay still for an additional 15 minutes (for Aim 1 cohort)
- Patients who are unable to lay still for 90 min for 18F-FDG scans or 100 min for 18F-AV1451 scans (for Aim 2 cohort)
- Patients who cannot follow the prep instructions
Key Trial Info
Start Date :
June 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04417998
Start Date
June 3 2020
End Date
December 20 2023
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905